In conclusion, these data extend our knowledge of hepatic CCN2 in NASH fibrosis by showing that CCN2 expression is associated with liver fibrosis severity, is principally induced in activated HSC and myofibroblasts, and exacerbates the degree of HSC activation and fibrosis in the context of NASH injury. Here, CCN2 is linked to metabolic dysfunction-associated steatohepatitis.